GFUZ

4.2009.68%
KD

Klaas de Boer

Independent Director

Mr. Klaas de Boer is Independent Chairman of General Fusion Group Ltd. and has been its Chairman of the Board since July 2020 and its Director since July 2019. Mr. de Boer was Executive Chairman of General Fusion Group Ltd. Mr. de Boer has been Independent Non-Executive Chairman of Xeros Technology Group plc since January 13, 2020. From January 2008 until June 2021, Mr. de Boer served as the Managing Partner of Entrepreneurs Fund Management LLP since January 2008 until June 2021, a venture capital firm. He joined Entrepreneurs Fund Management LLP in 2006 and served as Advisor to the Board of Entrepreneurs Fund B.V. Amsterdam. He serves as the Chief Executive Officer and Member of the Supervisory Board at De Boer Group. He has experience of venture capital spanning Europe, North America and the Middle East. He served as the Chief Executive Officer of De Boer International B.V. He has worked with entrepreneurial (technology) companies in Europe, Israel and the United States in the areas of finance, strategy and business development. He started his venture career, when he established and managed a corporate venturing team at Vanenburg Group. Prior to this, he served as a Strategy Consultant at McKinsey & Co. He has the venture experience. From 2001 to 2006, Mr. de Boer served as the Managing Director of Tsjukemar Ltd. He started his career in 1991 with McKinsey & Company in Amsterdam, where he served a wide range of clients. He served as the Chairman of the Supervisory Board at vasopharm GmbH until February 15, 2011 and serves as its Member of Supervisory Board. In 1997, he left and joined the then client Baan Investment, where he created and led a corporate venturing group, which invested in Europe, Israel and the US. He serves as a Vice Chairman of Heliocentris Fuel Cell Solutions GmbH. He served as a Non-Executive Director of Lifeline Scientific, Inc. since September 2008. He is Partner of Entrepreneurs Fund LP. He served as Vice Chairman of the Supervisory Board at Heliocentris Energy Solutions AG and has been its Member of Supervisory Board since June 16, 2015. He has been a Member of Advisory Board at OneMedPlace since April 2011. He serves as a Member of the Supervisory Board/Board Member of several technology companies in Europe and North America. He is a Representative of Entrepeneurs Fund. He serves as a Member of Advisory Board of vasopharm GmbH. He was also involved with the boards of Technolas Perfect Vision GmbH and Inge AG. He served as an Independent Director of SmartKem, Inc. since February 23, 2021. His Current Directorships & Partnerships includes: Entrepreneurs Fund Management Services Ltd; Tsjukemar Ltd; Park Road Associates Ltd; Vasopharm GmbH and Oomph Wellness Ltd. His Previous Directorships & Partnerships: GZPaul Investments Ltd; The New Motion BV; 2010 Perfect Vision AG and n-Tec AS He served as Non-Executive Director at Prosonix Ltd. He serves as a Member of the Supervisory Board at De Boer International BV. He served as Non-Management Director of Optinose, Inc. from 2010 to October 12, 2017. He served as a board member for veriNOS Pharmaceuticals GmbH, a biopharmaceutical company, from January 2023 to November 2024. He served as a Member of Supervisory Board at ProtAffin Biotechnologie AG. Mr. de Boer has a M.Sc. in Applied Physics from Delft University of Technology and an M.B.A. from INSEAD. He also serves as senior independent director of CelLBxHealth plc, also listed on AIM.

Positions